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have MRI abnormalities such as cartilage damage, bone marrow lesions,
or meniscal extrusion. Those with the medial regional pain were also
more likely to have meniscal damage (Table 1).
Table 1
Compartment-speciﬁc
MRI features*
Local Medial Joint Line
Pain (n =83)
Regional Medial Pain
(n =36)
Global Pain (n =27)
RRR [95%CI] RRR [95% CI] RRR [95% CI]
Cartilage damage 2.52 1.07 5.92 3.97 1.28 12.35 4.65 1.37 15.81
Bone marrow lesions 9.89 2.04 47.99 12.10 2.27 64.60 12.44 2.24 69.05
Synovitis/effusion** 0.99 0.46 2.14 1.62 0.61 4.28 0.94 0.31 2.79
Meniscal damage 1.46 0.56 3.77 3.72 1.10 12.60 2.65 0.77 9.11
Meniscal extrusion 1.08 0.47 2.49 8.77 2.18 35.23 3.46 1.00 12.05
*adjusted for age, sex and BMI and compared to knees with pain in the past 30 days; RRR= relative risk ratio,
CI = conﬁdence interval. ** Synovitis/effusion was read for the whole knee.
Based on the results from the table above, MRI features from the
medial compartment were then combined into a single multivariable,
multinomial model predicting each of the three patterns of knee pain.
In this single multivariate multinomial model taking into account all
the MRI features, bone marrow lesions were still signiﬁcantly associated
with local medial joint line pain, medial regional pain and global pain
when compared to no pain. RRRs and 95% CIs were 7.97 (1.48, 43.01),
8.56 (1.45, 50.4), and 8.04 (1.35, 48.0), respectively. Meniscal extrusion
was signiﬁcantly associated with medial regional pain, with an RRR of
6.76 (1.574, 29.05) after accounting for the other MRI abnormalities.
Conclusions: The presence of MRI-detected pathology was associated
with medial localized joint line pain, medial regional pain and global
pain patterns. Of note, meniscal extrusion was associated with the medial
regional knee pain pattern. The association of meniscal damage with
the medial regional knee pain pattern was no longer signiﬁcant after
accounting for meniscal extrusion. These ﬁndings may help to identify
more homogenous populations for targeted knee OA interventions.
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OSTEOARTHRITIS SEVERITY IS ASSOCIATED WITH INCREASED RISK
FOR DIABETES AND HEART DISEASE
G.A. Hawker, A. Warner, T. Simms. Women’s Coll. Hosp., Toronto, ON,
Canada
Purpose: Prior studies have documented increased rates of diabetes
and heart disease in individuals with versus without osteoarthritis (OA).
However, there is a paucity of research that has examined if OA severity
contributes independently to these relationships. Our study aim was to
evaluate the relationship between OA severity and prevalence of heart
disease and diabetes and the extent to which these relationships, if
found, were explained by common risk factors.
Methods: In a population cohort with hip and knee OA, standardized
interviews assessed sociodemographics, OA severity (WOMAC subscale
and summary scores), body mass index (BMI, from height and
weight), general health status (SF36) and comorbidity (list of 13 non-
musculoskeletal, MSK, conditions). Diabetes and heart disease were
deﬁned as present if the participant reported having ‘ever’ received a
diagnosis or received treatment in the past year. Logistic regression was
used to examine the association of OA severity with each of diabetes and
heart disease, ﬁrst unadjusted, then controlling for potential confounders
(age, sex, education, income, BMI and diabetes [heart disease model]).
We assessed for potential interactions between OA severity and age,
sex, education, and income, and between OA severity and diabetes on
heart disease. Statistical signiﬁcance was considered at a 2-tailed level
of 0.05.
Results: Participation rates were 80.6% and 75.4% for the rural and
urban regions, respectively. Analyses are based on 2,225 participants
with OA. Their mean age was 70.7 years, 72.0% were female and 96.1%
Caucasian; 81.1% reported ≤high school education and 63.9% reported an
annual income ≤ $20,000. WOMAC scores indicated moderate to severe
OA pain and disability. Participants’ mean BMI was 27.9 kg/m2; 38.8%
were overweight and 30.9% were obese. Three-quarters (73.1%) reported
receiving treatment for at least one other non-MSK chronic condition;
one-ﬁfth (22.5%) reported 3 or more comorbid conditions; 30.4% reported
heart disease and 16.8% reported diabetes. Unadjusted for other factors,
a 10-point increase in WOMAC summary scores was associated with
a 10% increase in the odds of self-reporting diabetes (odds ratio 1.10;
95% conﬁdence interval 1.04–1.16). This relationship was attenuated,
becoming non-signiﬁcant, after controlling for BMI. Unadjusted for other
factors, a 10-point increase in WOMAC summary scores was associated
with a 12% increase in the odds of reporting heart disease (odds ratio 1.12;
95% conﬁdence interval 1.06–1.17). In adjusted analyses, self-reported
heart disease was signiﬁcantly and independently associated with male
sex, lower income, and interactions between OA severity and each of age
(p value for the interaction = 0.015) and self-reported diabetes (p value
for the interaction = 0.02); the effect of a 10-point increase in WOMAC
summary scores on the odds of self-reporting heart disease decreased
with increasing age, but was signiﬁcantly greater at all ages among those
with than among those without comorbid diabetes. Results were similar
using the WOMAC pain or function subscale scores to deﬁne OA severity
(data not shown).
Conclusions: In a population cohort with moderately severe hip and
knee OA, the prevalence of comorbid diabetes and heart disease was
substantial and positively linked to increasing symptomatic OA severity.
For diabetes, this relationship was explained by a common risk factor,
obesity. For heart disease, this relationship remained signiﬁcant even
after controlling for common risk factors, and was stronger among
those with versus without comorbid DM. Prospective studies are needed
to further elucidate the causal relationships among these common
conditions.
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JOINT CHARACTERISTICS
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Purpose: Obesity is an important risk factor for osteoarthritis (OA). The
body mass index (BMI) is strongly associated with the prevalence and
incidence of knee OA. It is established that metabolic factors exert an
extra systemic effect on top of the mechanical effect of overweight in OA.
Adipose tissue is considered an endocrine tissue that releases cytokines,
such as IL-1 and TNFa, as well as adipokines, such as adiponectin, leptin,
and resistin. Adipokines have been reported to be involved in the disease
process. The exact mechanisms by which adipokines exert their effects in
OA are still unclear. The aim of this study is to compare serum adipokines
in end-stage OA with healthy controls and to evaluate the relationship
of these serum adipokines with actual cartilage damage and synovial
inﬂammation in the affected joint.
Methods: 172 successive patients with severe knee OA selected for total
knee replacement (TKR) surgery were included at the Sint Franciscus
Gasthuis, Rotterdam. Serum was collected shortly before TKR surgery.
Additionally from a healthy control (HC) group of 132 individuals without
any sign of radiographic knee OA serum was collected as well. Of all end-
stage OA patients and healthy individuals characteristics were collected
and serum adipokine (adiponectin, leptin and resistin) levels measured
by ELISA. Of the OA patients cartilage and synovial tissue were collected
at joint replacement surgery. Histological damage and proteoglycan
turnover and histological inﬂammation and IL-1b and TNFa production
were measured of cartilage and synovium, respectively. The study was
conducted according to the declaration of Helsinki and received ethics
approval of the hospital.
Results: In OA patients adiponectin levels were inversely related with
BMI (R = −0.218, p = 0.004) and positively correlated with age (R =0.283,
p = 0.000). Levels were higher in women than in men (24±13 and
14±7mg/ml, p = 0.000). Leptin levels showed a positive correlation with
patients BMI (R =0.604, p = 0.004 and R=0.495, p = 0.000, for OA and
HC, respectively). Leptin levels were also higher in women than in
men (90±64 and 33±28ng/ml, p = 0.000 in OA; 22±11 and 5.3±3ng/ml,
p = 0.000 in HC). In OA, resistin levels were inversely related with age
(R = −0.206, p = 0.012). Resistin levels did not differ between women and
men.
For the OA patients, all three adipokines correlated positively with
synovial inﬂammation. For adiponectin, leptin and resistin with synovial
tissue IL-1b production (p =0.02 all (p = 0.04 for women), p = 0.09 all, and
p=0.02 men, respectively). For leptin and resistin with synovial tissue
histological inﬂammation (p =0.06 all (p = 0.02 in men) and p=0.09 all,
respectively). For resistin with TNFa (p =0.09 all, p = 0.02 for men). None
of the adipokines showed an association with histological or biochemical
cartilage characteristics.
